Bio-Techne Corp develops, manufactures, and sells life science reagents, instruments, and services used in research, diagnostics, and bioprocessing. Its products support scientific work across protein analysis, molecular diagnostics, cell and gene therapy, and spatial biology. The company operates through two segments: Protein Sciences and Diagnostics and Spatial Biology. A meaningful part of the business is tied to recurring consumables demand from research labs, while another part serves regulated clinical and diagnostic workflows.
28,7 %
65,8 %
15,0 %
−0,4 %
4.55
3.35
| % | |
|---|---|
| Protein Sciences reagents | 72% Biological reagents used in life science research, diagnostics, and cell and gene therapy workflows. |
| Analytical solutions | 0% Proteomic tools and automated platforms used for protein analysis, western blotting, and multiplexed ELISA. |
| Diagnostics reagents and assays | 18% Controls, calibrators, and diagnostic assays sold into regulated diagnostics markets. |
| Spatial biology instruments and assays | 10% Instrumentation and tissue-based assays for spatial genomic analysis and biopsy workflows. |
Bio-Techne sells primarily to research institutions, pharmaceutical and biotechnology companies, and clinical...
Buys reagents and analytical tools for biological research, with demand tied to grant funding, lab activity, and academic calendars.
Buys protein science reagents, analytical platforms, and assay tools for drug discovery, development, and cell and gene therapy.
Buys diagnostic controls, calibrators, assays, and exosome-based tests for regulated clinical workflows.
Buys tissue-based in-situ hybridization assays and spatial genomic instrumentation for research and clinical applications.
Bio-Techne sells worldwide, with a broad international customer base across research and diagnostics markets...
Bio-Techne is focused on expanding its global sales force and distribution channels to make it easier for customers to...
Broader sales and distribution coverage helps capture demand across research and diagnostics markets and reduces dependence on any single channel.
Frequent new product introductions are essential in reagent and diagnostics markets where customers expect technical differentiation and workflow improvements.
Complementary acquisitions can add technology, customer relationships, and market access faster than internal development alone.
Bio-Techne faces intense competition from both large global life science companies and smaller niche players, which can...
The company competes against large multinationals and niche specialists, and consolidation among customers can concentrate buying power.
The business relies on manufacturing, packaging, warehousing, and distribution; any disruption can impair sales and customer trust.
Diagnostics and laboratory services are subject to healthcare, billing, and privacy rules that can trigger penalties or restrictions if breached.
Customer demand depends on research budgets, healthcare spending, and broader economic conditions.
BIO · Laboratory Analytical Instruments
Bio-Rad Laboratories is a U.S.-based multinational that develops, manufactures, and sells tools used in life science research and clinical diagnostics.
ADPT · Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp is a Seattle-based life sciences company built around immune-system sequencing and computational biology.
BNGO · Laboratory Analytical Instruments
BIVI · Pharmaceutical Preparations
BLFS · Electromedical & Electrotherapeutic Apparatus
RGEN · Biological Products, (No Diagnostic Substances)
: 11/08/2026